SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013539
Filing Date
2022-05-16
Accepted
2022-05-16 09:00:49
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 693802
2 ex10-1.htm EX-10.1 1000
3 ex10-2.htm EX-10.2 87237
4 ex31-1.htm EX-31.1 20308
5 ex31-2.htm EX-31.2 19726
6 ex32-1.htm EX-32.1 6016
7 ex32-2.htm EX-32.2 5335
8 ex10-1_001.jpg GRAPHIC 903858
  Complete submission text file 0001493152-22-013539.txt   5506016

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gtbp-20220331.xsd EX-101.SCH 46785
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gtbp-20220331_cal.xml EX-101.CAL 41160
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gtbp-20220331_def.xml EX-101.DEF 150156
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gtbp-20220331_lab.xml EX-101.LAB 349880
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gtbp-20220331_pre.xml EX-101.PRE 237000
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 549050
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 22925843
SIC: 2834 Pharmaceutical Preparations